Filing Details
- Accession Number:
- 0001127602-12-025173
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-27 15:39:54
- Reporting Period:
- 2012-08-24
- Filing Date:
- 2012-08-27
- Accepted Time:
- 2012-08-27 15:39:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
912183 | Cubist Pharmaceuticals Inc | CBST | Pharmaceutical Preparations (2834) | 223192085 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219023 | J W David Mcgirr | 65 Hayden Avenue Lexington MA 02421 | Svp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-08-24 | 20,000 | $10.35 | 37,200 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-08-24 | 20,000 | $45.69 | 17,200 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2012-08-24 | 20,000 | $0.00 | 20,000 | $10.35 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
25,000 | 2005-09-14 | 2015-06-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,280 | Indirect | 401(k) Plan |
Footnotes
- Sold pursuant to a Rule 10(b)5-1 Plan
- This transaction was executed in multiple trades at prices randing from $45.69 to $45.72. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- Option vests 6.25% quarterly over a four-year period.